Showing 1141-1150 of 1673 results for "".
- Oral GLP-1 Hits Phase 3 Trial Targets; Regulatory Submissions Cominghttps://modernaesthetics.com/news/oral-glp-1-hits-phase-3-trial-targets-regulatory-submissions-coming/2483149/Eli Lilly and Company announced positive topline results from its Phase 3 ATTAIN-2 trial, showing that its investigational oral GLP-1 receptor agonist, orforglipron, achieved significant weight loss and improved cardiometabolic outcomes in adults with obesity or overweight status and type 2 diabe
- Korean Skincare Brand Launches in US with Sensitive-Skin Formulationshttps://modernaesthetics.com/news/korean-skincare-brand-launches-in-us-with-sensitive-skin-formulations/2483054/South Korean skincare brand Hexkin has entered the US market, offering products formulated for sensitive skin using collagen-based and peptide-driven technologies, according to a press release. Rooted in traditional Korean sk
- New Website Streamlines Laser Therapy Device Selectionhttps://modernaesthetics.com/news/new-website-streamlines-laser-therapy-device-selection/2482984/ColdLasers.org has launched LaserTherapy.com, a redesigned platform aimed at simplifying the process of selecting therapeutic laser devices. The site offers a modern interface, comparison tools, and updated educational content designed to support informed decision-making. The platform addr
- SSS 2025: Focus on Disruptive Dermatology Innovationshttps://modernaesthetics.com/news/sss-2025-focus-on-disruptive-dermatology-innovations/2482982/The 2025 Science of Skin Summit will debut a new Innovations Forum feature this year dedicated to transformative products and emerging technologies shaping the future of dermatology. Scheduled for Saturday, September 6, 2025,
- JUVÉDERM Day Returns with Limited-Time Offers Through Rewards Programhttps://modernaesthetics.com/news/juvederm-day-returns-limited-time-offers-through-rewards-program/2482957/Members of JUVÉDERM’s Alle loyalty rewards program will have an opportunity to purchase “buy one, get one” gift cards as part of JUVÉDERM Day on August 20, according to Allergan Aesthetics, an AbbVie company. Details of the exclusive, limited limited-time offers are as follows: •
- Noninvasive Brain Stimulation for Mental Wellness Coming to Illinois Dermatology Clinichttps://modernaesthetics.com/news/noninvasive-brain-stimulation-mental-wellness-coming-illinois-dermatology-clinic/2482956/An Illinois dermatology clinic is now offering a noninvasive brain stimulation treatment for patients experiencing depression, anxiety, and related mental health concerns. Dundee Dermatology recently introduced EXOMIND, a transcranial magnetic stimulation (TMS) device that is FDA
- TOPICAL SKIN Launches Antioxidant Face Oilhttps://modernaesthetics.com/news/topical-skin-launches-antioxidant-face-oil/2476145/Skincare brand TOPICAL SKIN launched Phyto AOX Face Oil N°10, a plant-based facial oil developed to protect the skin from environmental damage such as pollution, UV rays, and blue light. The formula features a proprietary Exposome Defense Technology, describ
- Alma Introduces PixelPeel™ Laser Peel for Minimal-Downtime Skin Renewalhttps://modernaesthetics.com/news/alma-introduces-pixelpeel-laser-peel-for-minimal-downtime-skin-renewal/2476137/Alma has launched PixelPeel™, a new fractional laser peel treatment designed for subtle, controlled skin resurfacing with minimal recovery time. The treatment is compatible with the Alma Pixel™ and Alma Hybrid® platforms and uses the company’s MotionSync™ technology to deliver uniform exfoliation
- AMI Pharm Advances AYP-101 to Phase 3 Testing for Noninflammatory Fat Reductionhttps://modernaesthetics.com/news/ami-pharm-advances-ayp-101-to-phase-3-testing-for-noninflammatory-fat-reduction/2476093/AMI Pharm has initiated a pivotal Phase 3 clinical trial of AYP-101, an investigational injectable for the treatment of submental fat. The study will evaluate the efficacy and safety of the agent, which is designed to reduce localized fat with fewer inflammatory side effects than current therapie
- ProRx Highlights Role of 503B Outsourcing in Patient-Centered Wellness Carehttps://modernaesthetics.com/news/prorx-highlights-role-503b-outsourcing-patient-centered-wellness-care/2476084/In recognition of National Wellness Month, ProRx, an FDA-registered 503B outsourcing facility, is emphasizing the clinical value of personalized, high-quality compounded therapies in wellness-focused care models. ProRx provides sterile and non-sterile compounded medications for office use